🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study seeks to determine if addition of trabectedin (T) to combination...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-06
Trial ID
NCT03437070
Treatments Being Tested
This is a feasibility study in patients with localized or metastatic soft t...
Status
Completed
Location
Monter Cancer Center (Northwell Health)
Start Date
2016-12-15
Trial ID
NCT03056599
Treatments Being Tested
The main purpose of this study is to evaluate the safety of different doses...
Status
Completed
Location
Phoenix Childrens Hospital
Start Date
2016-08-29
Trial ID
NCT02677116
Treatments Being Tested
Phase I, multicentre clinical trial of olaratumab plus trabectedin in patie...
Status
Unknown
Location
GEIS
Start Date
2018-09-21
Trial ID
NCT03985722
Treatments Being Tested
The purpose of this study is to evaluate the safety of olaratumab plus pemb...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2017-07-03
Trial ID
NCT03126591
Treatments Being Tested
The purpose of this study is to evaluate potential biomarkers and method of...
Status
Completed
Location
USC/Norris Comp Cancer Center
Start Date
2016-10-11
Trial ID
NCT02783599
Treatments Being Tested
The purpose of this study is to determine if participants with untreated lo...
Status
Completed
Location
ImClone Investigational Site
Start Date
2010-01
Trial ID
NCT00918203
Treatments Being Tested
The purpose of this study is to evaluate the tumor response of stable disea...
Status
Terminated
Location
ImClone Investigational Site
Start Date
2011-08
Trial ID
NCT01316263
Treatments Being Tested
This study consists of 2 parts (Part A and Part B). The main purpose of Par...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician.
Start Date
2015-03-23
Trial ID
NCT02377752
Treatments Being Tested
The main purpose of this study is to gather information about the use of an...
Status
Completed
Location
ImClone Investigational Site
Start Date
2010-10
Trial ID
NCT01185964
Treatments Being Tested